HTL-STREFA, Inc., An MTD Company | Finanzwire

Basculer en Français

8295	Companies
114833	Keywords
55274	Articles
62430	Press releases

Headlines Articles Press releases HTL-STREFA, Inc., An MTD Company

Home
Companies
HTL-STREFA, Inc., An MTD Company

BRIEF

published on 04/17/2024 at 12:05, 7 months 3 days ago

Droplet Micron Receives Expanded FDA Approval and OTC Availability

Pharmaceuticals Medical Devices FDA Approval Healthcare Access OTC Availability
PRESS RELEASE

published on 04/17/2024 at 12:00, 7 months 3 days ago

Droplet Micron Launches Expanded Indication and OTC Availability
Droplet Micron expands indication for subcutaneous drug injection beyond insulin, now available OTC in the USA. HTL-Strefa introduces innovative pen needle technology

OTC Availability Droplet Micron Subcutaneous Injection HTL-Strefa Pen Needle Technology
BRIEF

published on 03/27/2024 at 13:35, 7 months 24 days ago

HTL-STREFA Inc. Introduces DropSafe® Sicura™ as a Safe Alternative Amid FDA Concerns

Medical Devices Patient Safety HTL-Strefa Inc. DropSafe® Sicura™ FDA Concerns
PRESS RELEASE

published on 03/27/2024 at 13:30, 7 months 24 days ago

Amid FDA Concerns, HTL-Strefa Inc. Offers a Reliable and Safe Alternative to Chinese Supplied Needles & Syringes With European-Produced Sicura(TM) Passive Safety Needle
HTL-Strefa Inc. introduces DropSafe Sicura, the first fully passive safety needle in North America, offering a safe injection experience amidst FDA concerns over Chinese-manufactured safety needles

HTL-Strefa Inc. Passive Safety Needle FDA Concerns DropSafe Sicura Injection Safety
BRIEF

published on 03/22/2024 at 22:10, 7 months 29 days ago

HTL-Strefa Inc. Presents DropSafe® Sicura™, A European-Made Passive Safety Needle, Amid FDA Concerns Over Chinese Medical Supplies

Healthcare Safety HTL-Strefa Inc. DropSafe® Sicura™ Passive Safety Needle FDA Concerns
PRESS RELEASE

published on 03/22/2024 at 22:05, 7 months 29 days ago

Amid FDA Concerns of Chinese Supplied Needles & Syringes, HTL-Strefa Inc. Offers a Reliable and Safe Alternative With Its European-Produced Passive Safety Needle, Sicura TM
HTL-Strefa Inc. introduces DropSafe® Sicura™, the first fully passive safety needle in North America, offering a safe injection experience. FDA-cleared and European-made, it aligns with top patient care standards

Patient Care HTL-Strefa Inc. DropSafe® Sicura™ Passive Safety Needle FDA-cleared

Accesswire

Published on 11/21/2024 at 10:03, 47 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 50 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 50 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 15 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 25 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:30, 20 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 45 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 47 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 50 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 50 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 52 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 30 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 5 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 5 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE